C0751968||activators
C0086418||human
C0914906||constitutive androstane receptor
C0026383||structure
C0025663||methods
C0914906||constitutive androstane receptor
C0914906||constitutive androstane receptor
C0663285||NR1I3)
C2755857||regulates the expression
C0683140||drug-metabolizing
C0014442||enzymes
C0007292||transporters
C0041904||upregulation
C0014442||enzymes
C0534137||CYP2B6
C0914906||constitutive androstane receptor
C0751968||activators
C0687133||drug-drug interactions
C0687133||drug-drug interactions
C1516769||computational approaches
C0914906||constitutive androstane receptor
C3161035||models
C0914906||constitutive androstane receptor
C1514758||activating
C1254351||compounds
C0920472||drug-discovery
C3161035||Models
C1513380||comparative molecular field analysis
C1513380||comparative molecular field analysis
C1517880||ligands binding
C0914906||constitutive androstane receptor
C1522290||ligand-docking
C1254351||28 compounds
C1513380||comparative molecular field analysis
C3161035||model
C3161035||model
C0914906||constitutive androstane receptor
C1514758||activation
C1254351||compounds
C1519941||external validation
C3161035||model
C0914906||constitutive androstane receptor
C1514758||activating
C1254351||drug candidates
C0687133||DDI
C0014431||enzyme-induction
C0920472||drug-discovery